But even as he calls for more robust data on long-term outcomes and safety in older adults, Batsis says that his skepticism regarding the benefits of these drugs has decreased over the past few years

As off-label use continues to expand, particularly among patients with obesity or insulin resistance, our findings suggest GLP-1based therapies may warrant consideration as an adjunct to insulin in carefully selected patients. Advertisement Advertisement New service for patients with diabetes will make annual screening more convenient Association revises criteria for the diagnosis and resolution of severe conditions What to consider in the management of euglycemic DKA Less than 50% of patients with diabetes get appropriate ophthalmic screening through primary care referrals Familiarity will enhance its accessibility for patients with diabetes New study counters earlier findings linking drugs with eye disease Study highlights the value of quantitative ultra-widefield angiography Longevity in healthcare, personal experiences may provide caregivers with false sense of confidence
Jan-Feb 2007;13(1):103-109
While it treats diabetes, Semaglutide is also used to treat obesity
Semaglutide 0.25 mg Starter Dose for Medical Weight Loss Your first step toward sustainable, physician-guided weight loss
The total flavonoids of Rhizoma Drynaria can prevent oxidative stress and hepatic lipid deposition, reverse hepatic ferroptosis by improving the host intestinal microenvironment, and play a protective role in aflatoxin B1-induced liver damage [85]